This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Wheelock that the negative results of our trial do not rule out the possibility that other modes of delivery of ESWT may or may not be efficacious for this condition. In particular, our study does not provide any data about the efficacy of single-dose high-energy ESWT. However, the mean total dose that the active group received was 1401.7 mJ/mm², which is higher than the 1300 mJ/mm² total dose delivered to patients in the active groups of both previous trials of single-dose high-energy ESWT.^1-2 In our trial, the device energy was increased to the highest tolerable level of pain in the active group, aiming for a total dose of >1000 mJ/mm², and, as we reported, our results were consistent irrespective of total dose of ESWT received. The same procedure was simulated in the placebo group.

We strongly disagree with Dr Theodore that the . . . [Full Text of this Article]

RELATED ARTICLES

Shock Wave Therapy for Treatment of Plantar Fasciitis
Argil J. Wheelock
JAMA. 2003;289(2):172.
EXTRACT | FULL TEXT  

Shock Wave Therapy for Treatment of Plantar Fasciitis
George H. Theodore
JAMA. 2003;289(2):172.
EXTRACT | FULL TEXT  

Shock Wave Therapy for Treatment of Plantar Fasciitis
Steven Miller
JAMA. 2003;289(2):172.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronic Plantar Fasciitis: Acute Changes in the Heel after Extracorporeal High-Energy Shock Wave Therapy--Observations at MR Imaging
Zhu et al.
Radiology 2005;234:206-210.
ABSTRACT | FULL TEXT